行情

SVA

SVA

科兴生物
NASDAQ

实时行情|Nasdaq Last Sale

6.47
0.00
0.00%
休市 16:00 01/24 EST
开盘
--
昨收
6.47
最高
--
最低
--
成交量
--
成交额
--
52周最高
6.69
52周最低
6.25
市值
6.40亿
市盈率(TTM)
37.70
分时
5日
1月
3月
1年
5年

SVA 新闻

  • Week In Review: Geneseeq And Elpiscience Close $100 Million VC Rounds; Zai Lab's PARP Inhibitor Approved For China Use
  • Seeking Alpha - Article.2019/12/31 03:10
  • Sinovac Biotech's chicken pox vaccine gets approval in China
  • Seeking Alpha - Article.2019/12/27 14:10
  • Sinovac Biotech Reports Approval Of Varicella Vaccine For Prevention Of Varicella-Zoster Virus In Children
  • Benzinga.2019/12/27 14:00
  • Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children
  • Business Wire.2019/12/27 14:00

更多

所属板块

制药
-1.84%
制药与医学研究
-2.00%

热门股票

名称
价格
涨跌幅

SVA 简况

Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.
展开

Webull提供Sinovac Biotech Ltd.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。